Michael Westby

817 citations

18 papers · 596 indexed · h-index 13

Impact in

Virology top 5%
- HIV Research and Treatment
Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Toxin Mechanisms and Immunotoxins

Papers in

Virology 6
- HIV Research and Treatment 6
Immunology 11
- Immune Cell Function and Interaction 6
- T-cell and B-cell Immunology 4
- Immunotherapy and Immune Responses 2

Co-authors: Angus Dalgleish J B Marriott David Stirling Sharon Cookson Mary Guckian Stephen Goodbourn George W. Muller Fabrizio Manca
Journals: British Journal of Cancer (1 paper)British Journal of Haematology (1 paper)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)FEBS Letters (1 paper)Cytometry (1 paper)
Partner nations: United Kingdom United States Italy

In The Last Decade

Michael Westby

18 papers receiving 575 citations

Peers

Countries citing papers authored by Michael Westby

Since Specialization

Citations

This map shows the geographic impact of Michael Westby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Westby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Westby more than expected).

Fields of papers citing papers by Michael Westby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Westby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Westby. The network helps show where Michael Westby may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Westby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Westby Line = papers co-authored together Michael Westby links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Preclinical Studies of Pf-04849285, An Interferon-α8 Fusion Protein for the Treatment of HCV Antiviral Therapy ·María Victoria Flores, Timothy P. Hickling, Sasha Sreckovic, Mark Fidock, Nigel Horscroft, Madan Katragadda, Klea Rota, S Ravi, 悦三山下, Nicola Robas, Усмонов Хуршиджон Рашид Угли, А. А. Вавер, Michael T. Lawton, John Marcek, Marta Cappellini, Michael Westby, Giuseppe Ciaramella	2012	4
2	The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691) Clinical Pharmacology & Therapeutics ·Mark Fidock, Ben Saletta, Carl Laxton, S Ravi, 悦三山下, U. Bergdahl, Peter Colman, Vinay Kumar, T. Shatti, Katherine Wright, Subasree Srinivasan, Khurram Rana, Charles Craig, Nigel Horscroft, Manos Perros, Michael Westby, Robert O. Webster, Elna van der Ryst	2011	64
3	Disease-Modifying Therapeutic Concepts for HIV in the Era of Highly Active Antiretroviral Therapy JAIDS Journal of Acquired Immune Deficiency Syndromes ·Scott L. Butler, Hernán Valdez, Michael Westby, Manos Perros, Carl H. June, Jeffrey M. Jacobson, Yves Lévy, David A. Cooper, Daniel C. Douek, Michael M. Lederman, Pablo Tebas	2011	17
4	Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors Antiviral Research ·Michael Westby, Grace R Nakayama, Scott Butler, Wade Blair	2005	34
5	HIV gp120 Plus Specific Peptides Are Recognized in a Similar Manner to Specific HLA Plus Peptide by HLA-Restricted Antigen-Specific T-Cell Lines Viral Immunology ·幸子外山, B.E. Souberbielle, Michael Westby, Brian Austen, Angus Dalgleish	2000	8
6	Flow cytometric visualisation of cytokine production by CD3-CD56+ NK cells and CD3+CD56+ NK-T cells in whole blood Cytometry ·R. Mendes, Keyla Esthepania, Michael Westby, Joanna Galea‐Lauri, Ian E. Smith, Mary O’Brien, B.E. Souberbielle	2000	51
7	A whole blood facscan assay to look at cytokine production by NK cells in cancer patients. British Journal of Cancer ·R. Mendes, Keyla Esthepania, Michael Westby, Joanna Galea‐Lauri, Ian E. Smith, Thejus Varghese, B.E. Souberbielle	1999	15
8	Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interkukin-2 in peripheral blood lymphocytes Annals of Oncology ·Anthony Maraveyas, Babak Baban, Setz Cañadas, G.A.W. Rook, Michael Westby, John M. Grange, P M Lydyard, J.L. Stanford, Mark B. Jones, P Selby, Angus Dalgleish	1999	56
9	Comparison of four strategies for tumour vaccination in the B16-F10 melanoma model Gene Therapy ·B.E. Souberbielle, Michael Westby, Г.Ш. Мингулов, 哲男小佐田, R. Mendes, Gustavo Miranda, AG Dalgleish	1998	18
10	Low CD4 counts rather than superantigenic‐like effects account for differences in expressed T‐cell receptor (TCR) repertoires between HIV‐1 seropositive long‐term non‐progressors and individuals with progressive disease British Journal of Haematology ·Michael Westby, Andrew N. Vaughan, Claudia Balotta, Massimo Galli, Mario Clerici, Angus Dalgleish	1998	11
11	Repertoire Breadth of Human CD4+ T Cells Specific for HIV gp120 and p66 (Primary Antigens) or for PPD and Tetanus Toxoid (Secondary Antigens) Human Immunology ·Giuseppina Li Pira, Fazl Ahmed Bawar, Marco Seri, Michael Westby, Francesco Caroli, Daniela Fenoglio, Pei XinWu, Arnaud Ferraris, Darren Hayashi, Maria Teresa Valle, Annalisa Kunkl, G. Romeo, Angus Dalgleish, Fabrizio Manca	1998	18
12	CC-3052: A Water-Soluble Analog of Thalidomide and Potent Inhibitor of Activation-Induced TNF-α Production The Journal of Immunology ·J B Marriott, Michael Westby, Sharon Cookson, Mary Guckian, Stephen Goodbourn, George W. Muller, Rafael Micó Pérez, David Stirling, Angus Dalgleish	1998	72
13	CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production. PubMed ·J B Marriott, Michael Westby, Sharon Cookson, Mary Guckian, Stephen Goodbourn, George W. Muller, Britta Kleemann, David Stirling, Angus Dalgleish	1998	86
14	Therapeutic potential of TNF-α inhibitors old and new Drug Discovery Today ·J B Marriott, Michael Westby, Angus Dalgleish	1997	42
15	The role of host immune responses in determining the outcome of HIV infection Immunology Today ·Michael Westby, Fabrizio Manca, Angus Dalgleish	1996	51
16	Preparation and characterization of recombinant proricin containing an alternative protease-sensitive linker sequence Bioconjugate Chemistry ·Michael Westby, Richard H. Argent, Rizal Rizal, Jonathan Lord, Lynne M. Roberts	1992	5
17	Recombinant proricin binds galactose but does not depurinate 28 S ribosomal RNA FEBS Letters ·Peter T. Richardson, Michael Westby, Lynne M. Roberts, Jane H. Gould, Alan Colman, Jonathan Lord	1989	35
18	Amino acid sequences of two atypical single-chain vicieae isolectins from seeds of Lathyrus nissolia Phytochemistry ·A. Yarwood, Michael Richardson, Ichiro Matsutani, Michael Westby, Ю.М. Довіденко, Pierre Rougé	1988	9

About Michael Westby

Michael Westby is a scholar working on Virology, Immunology, Toxicology, Hepatology and Pharmacology, having authored 18 papers that have together received 596 indexed citations. Recurring topics across this work include HIV Research and Treatment (6 papers), Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (4 papers), HIV/AIDS Research and Interventions (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Signaling Pathways in Disease (2 papers), CAR-T cell therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Virology (106 citations), Immunology (289 citations), Hematology (90 citations), Biotechnology (51 citations) and Infectious Diseases (93 citations). Michael Westby has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Angus Dalgleish, J B Marriott, David Stirling, Sharon Cookson, Mary Guckian, Stephen Goodbourn, George W. Muller, Fabrizio Manca, B.E. Souberbielle and R. Mendes. Their work appears in journals such as British Journal of Cancer, British Journal of Haematology, JAIDS Journal of Acquired Immune Deficiency Syndromes, FEBS Letters and Cytometry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact